Efficacy of abatacept for IgG4-related disease over 8 months.
about
Recent advances in understanding and managing IgG4-related diseaseOphthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.Diagnostic and treatment workup for IgG4-related disease.A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.Follicular helper T cells in the pathogenesis of IgG4-related disease.Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies.Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.Response to: 'Could abatacept directly target expanded plasmablasts in IgG4-related disease?' by Alegria et al.Frequency and distribution of CD4+CXCR5+ follicular B helper T cells within involved tissues in IgG4‑related ophthalmic disease.Immunoglobulin G4-related kidney diseases: An updated review.
P2860
Q37664754-7E00D42D-7444-48D9-A807-D71DF6A26AB2Q37696839-E2805F02-CB15-4FEA-9A0D-D355C79918C8Q38682216-C0A0A442-00DF-4459-A279-0BFA06773716Q39009464-1B2CE58F-DB77-4FBB-8E9D-5E3C49FE32D4Q39275481-F11F0AB9-123F-44D9-A6C1-EB925656F3EBQ39346488-A5D212F1-3092-4478-958F-C24016446627Q40043818-3BD23282-FBE2-48CA-BB1D-E43BB70FFDAAQ44403879-3DBE0750-C323-4AD6-B620-63A10BF6CB69Q47641178-3BF2EB52-9102-4894-881A-450E5FC6ADDCQ49279265-462B52C8-5F15-4708-B57F-0C2FCA56CEED
P2860
Efficacy of abatacept for IgG4-related disease over 8 months.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy of abatacept for IgG4-related disease over 8 months.
@en
Efficacy of abatacept for IgG4-related disease over 8 months.
@nl
type
label
Efficacy of abatacept for IgG4-related disease over 8 months.
@en
Efficacy of abatacept for IgG4-related disease over 8 months.
@nl
prefLabel
Efficacy of abatacept for IgG4-related disease over 8 months.
@en
Efficacy of abatacept for IgG4-related disease over 8 months.
@nl
P2093
P2860
P1476
Efficacy of abatacept for IgG4-related disease over 8 months.
@en
P2093
Chisako Suzuki
Hidetaka Yajima
Hiroki Takahashi
Hiroshi Nakase
Kenichi Takano
Motohisa Yamamoto
Nodoka Sakurai
Teruhito Awakawa
Tetsuo Himi
Yasuyoshi Naishiro
P2860
P304
P356
10.1136/ANNRHEUMDIS-2016-209368
P407
P577
2016-05-04T00:00:00Z